FeesSafety
Pluang+

Wesdome Gold misses Q3 production target; Q4 output crucial to meet 2026 guidance.

Market News
29 Oct 2026, 16:45 WIB
Seeking Alpha
View Source
Neutral
Wesdome Gold misses Q3 production target; Q4 output crucial to meet 2026 guidance.

Wesdome Gold Mines reported Q3 production of 41,287 ounces, missing targets due to maintenance downtime at Kiena and blending early ore from Presqu'ile. Eagle River set a record with 79,820 tonnes milled. The company expects 2026 production to be below the midpoint of 192,500 ounces, requiring about 49,600 ounces in Q4 to meet the guidance floor. Shares trade slightly below risked NAV, with a price target of US$21.00, reflecting cautious optimism amid operational challenges.

Wesdome Gold Mines Q3 production results provide context for Basic Materials sector activity on Pluang. For readers following this sector, breadth was 17 gainers and 65 losers among 83 priced US stocks. Notable movers as of Oct 29, 2026 20:02 WIB include HYMC at USD 16.68 (-4.36%), AMRZ at USD 38.35 (-4.20%), and AEM at USD 176.39 (-3.67%) with 100% buy order activity.

More News

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...

Market News
Bullish
1 hour ago
Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...

Company Fundamentals
Bullish
1 hour ago
Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...

Others
Bullish
2 hours ago
Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...

Market News
Neutral
2 hours ago
Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App